You are here: Industry Insights > Moderna

News List

Taiwan, China starts study on efficacy of mixing AZ, Moderna COVID vaccines firstwordpharma
August 02, 2021
A hospital in Taiwan, China has begun a clinical study investigating a mix and match approach with COVID-19 vaccines from AstraZeneca and Moderna, Taiwan, China News reported.
Pfizer and Moderna raise prices for its COVID-19 vaccines in EU firstwordpharma
August 02, 2021
According to the Financial Times, Pfizer and Moderna have raised the prices of their COVID-19 vaccines in their latest supply contracts with the EU, as reported Sunday in Investing.com.
EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds pharmatimes
July 28, 2021
Moderna’s COVID-19 vaccine has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for use in adolescents aged 12 to 17 years of age.
Pfizer, Moderna to Expand Vaccine Studies in Young Children drugs
July 28, 2021
Pfizer and Moderna are expanding trials of their COVID-19 vaccines in children ages 5 to 11 years to more closely measure the risk for heart inflammation and other rare side effects that occurred in teens and young adults who received the vaccines.
EMA committee recommends Moderna’s Covid-19 vaccine for adolescents pharmaceutical-technology
July 27, 2021
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the marketing authorisation of the Moderna Covid-19 vaccine, Spikevax, for adolescents aged 12 to 17 years.
COVID-19 vaccine market set to reach $19.5bn by 2026 pharmaceutical-technology
July 26, 2021
The size of the COVID-19 vaccine market across the seven major markets – the US, Germany, France, Italy, Spain, the UK, and Japan -will increase from $13.6bn in 2021 to $19.5bn in 2026 at a compound annual growth rate (CAGR) of 7.6% should annual ...
Take your best shot: Which SARS-CoV-2 vaccine should I get, if any? worldpharmanews
July 22, 2021
Vaccine hesitancy continues to be a hurdle in the development of widespread immunity within the U.S. population as the COVID-19 pandemic enters its second year.
Takeda expands Covid-19 vaccine supply deal with Moderna pharmaceutical-technology
July 22, 2021
Takeda Pharmaceutical has entered a new agreement with Moderna and the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) to import and supply 50 million doses of Moderna’s mRNA Covid-19 vaccine in the country.
Startups join CSL, Moderna in local mRNA vaccine manufacturing push firstwordpharma
July 22, 2021
Australian biotech startups and small businesses have joined pharmaceutical majors like CSL in pitching to the federal government for a role in making mRNA products in the country, reported The Age.
Moderna to join S&P 500, shares jump after hours firstwordpharma
July 16, 2021
In a statement on Thursday, S&P Dow Jones Indices said Moderna will join the S&P 500 index as of the start of trading on July 21, replacing Alexion Pharmaceuticals, as reported by Investing.com.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page